Marc Moret, 82; Led Merger That Created Drug Giant Novartis
Marc Moret, 82, the former chief executive who organized a merger of major Swiss pharmaceutical companies that created Novartis AG, died Friday.
Moret died after an extended illness, said Novartis spokesman John Gilardi.
As chief executive of Sandoz AG in 1996, he was an influential force in the company’s merger with Ciba Geigy -- a $29-billion transaction that created Novartis, then the world’s second-largest drug maker.
Although his understudy, Daniel L. Vassella, was named chief executive of the new firm, Moret served as an honorary president of the company until his death.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
